About Cipla Health Limited
Data last updated:
Cipla Health Limited is a public limited company based in Mumbai, Maharashtra, India, a subsidiary of Cipla Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 August 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2015PLC267880. Its GSTIN is 27AAGCC1585R1ZZ (Maharashtra). The company holds 26 GST registrations, of which 24 are active.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹2.33 Cr. It is led by directors including Shivam Puri (Managing Director) and Geena Malhotra.
Its last annual general meeting (AGM) was held on 02 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹1,228.87 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹118.56 Cr (net margin 9.6%) and EBITDA of ₹185.55 Cr (EBITDA margin 15.1%). Revenue has grown at a compounded annual rate (CAGR) of 33% over three years and 43% over five years.
The company has about 363 employees on its provident fund (EPFO) records.
The company is associated with 5 brands: Nicotex, Mamaxpert, Maxirich, Asta Berry Biosciences and Cipla Health. Court records list 31 cases involving the company, including 27 filed by the company and 4 filed against it; 17 cases are pending. The company has 8 deals on record (3 rights issues, 3 secondary share transfers, 2 funding rounds), with disclosed funding of ₹145.23 Cr; the latest was in March 2021. Its 8 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 5 smaller; the largest is Encube Ethicals Private Limited with revenue of ₹1,369 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ciplahealth.in.
Company details
Contact details
Cipla Health Limited's registered office is in Mumbai, Maharashtra. Its website is ciplahealth.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressFofb – 11 B Wing Fourth Floor Art Guild House Phoenix Marketcity L.B.S Marg Kurla (W, Est), Mumbai, Maharashtra, India – 400070
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Cipla Health Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Cipla Health operates multiple associated brands including Nicotex, Mamaxpert, and Maxirich. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers nicotine gums, mints, patches, and wellness items for quitting smoking. | nicotex.in | |
| Runs a direct-to-consumer brand specializing in skincare products for moms and babies. | mamaxpert.com | |
| Ayurvedic skincare and cosmetics are manufactured and distributed globally. | astaberry.com | |
| Consumer healthcare products including supplements and remedies are provided. | ciplahealth.in | |
| Nutritional supplements including multivitamins, omega 3 capsules, and tonics for health support. | maxirich.com |
Business activity
The main business activities of Cipla Health are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Cipla Health Limited, buy the company report.
Financials of Cipla Health Limited
FY 2025 filings availableCipla Health Limited reported revenue of ₹1,228.87 Cr (up 17% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 43% over five years, including 17% growth in the latest year. EBITDA rose 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹1,228.87 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹185.55 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹118.56 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.1% | ||||
| Net Profit Margin | 9.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cipla Health Limited, buy the company report.
Board of directors of Cipla Health Limited
Cipla Health has 6 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Geena Malhotra | Director | 08 May 2024 | 2 Years 5 Months | Current |
| Umang Vohra Also directs: Cohance Lifesciences Limited, Stempeutics Research Private Limited | Director | 29 Nov 2022 | 3 Years 11 Months | Current |
| Chandrashekhar Ramachandran Iyer Also directs: Jay Precision Pharmaceuticals Private Limited | Director | 27 Mar 2019 | 7 Years 7 Months | Current |
| Shivam Puri | Managing Director | 01 Apr 2022 | 4 Years 7 Months | Current |
| Achin Gupta | Director | 15 Feb 2022 | 4 Years 8 Months | Current |
| Amrita Nautiyal | Director | 27 Mar 2019 | 7 Years 7 Months | Current |
Peer comparison
Cipla Health Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Encube Ethicals Private Limited | ₹1,369 Cr (FY 2025) | 25.0% | Mumbai, Maharashtra, India | |||
| Sentiss Pharma Private Limited | ₹1,262.74 Cr (FY 2025) | 43.0% | New Delhi, Delhi, India | |||
| Innova Captab Limited | ₹1,255.72 Cr (FY 2025) | 15.0% | Thane, Maharashtra, India | |||
| Cipla Health Limitedthis company | ₹1,228.87 Cr (FY 2025) | ₹118.56 Cr | 9.6% | 17.0% | 363 | Mumbai, Maharashtra, India |
| Neon Laboratories Limited | ₹1,222.81 Cr (FY 2025) | 4.0% | Mumbai, Maharashtra, India | |||
| Corona Remedies Limited | ₹1,202.35 Cr (FY 2025) | 18.0% | Ahmedabad, Gujarat, India | |||
| Hetero Healthcare Limited | ₹1,189.8 Cr (FY 2025) | 16.0% | Hyderabad, Telangana, India | |||
| BDR Pharmaceuticals International Private Limited | ₹1,137.31 Cr (FY 2025) | 2.0% | Mumbai, Maharashtra, India | |||
| Tirupati Medicare Limited | ₹1,119.15 Cr (FY 2025) | 6.0% | New Delhi, Delhi, India |
To see the full peer comparison of Cipla Health Limited, buy the company report.
Auditor
Cipla Health Limited is audited by Walker Chandiok & Co LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Walker Chandiok & Co LLP | FY 2023 | 001076N/N500013 |
Shareholding
The shareholding of Cipla Health Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Cipla Health Limited, buy the company report.
Deals & funding
Cipla Health Limited has 8 deals on record (3 rights issues, 3 secondary share transfers, 2 funding rounds), with disclosed funding of ₹145.23 Cr; the latest was in March 2021.
Deals on record (5 of 8)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: Cipla Limited Seller: Eight Roads Ventures |
| Dec 2019 | Rights issue | ₹140 Cr | Investors: Cipla Limited |
| Aug 2019 | Secondary share transfer | Undisclosed | Buyer: Cipla Limited Seller: Eight Roads Ventures |
| Aug 2018 | Rights issue | ₹43.73 Cr | Investors: Cipla Limited |
| Mar 2016 | Rights issue | ₹56.95 Cr | Investors: Cipla Limited |
To see the full deal history of Cipla Health Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Cipla Health Limited has 31 court cases on record: 27 filed by Cipla Health, 4 filed against it. 17 cases are pending and 14 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 15 | 2 | 13 |
| High courts | 15 | 2 | 4 |
| Supreme Court | 1 | 0 | 0 |
Cases on record (5 of 31)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed by the company against Maxx Farmacia India LLP & Ors. | Pending |
| High Court of Delhi | Commercial suit | Filed by the company against Micro Labs Limited & Ors. | Pending |
| District court, Varanasi, Uttar Pradesh | Criminal case | Filed by the company against Kelvin Life Sciences Pvt. Ltd. and Ohers | Pending |
| High Court of Delhi | Commercial suit | Filed by the company against Brisc Healthcare Private Limited & Ors. | Disposed |
| High Court of Delhi | Commercial suit | Filed by the company against Aristo Pharmaceuticals Pvt. Ltd. & Anr. | Disposed |
To see the full case history of Cipla Health Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cipla Health Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Cipla Health Limited has a workforce of 363 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
GST
Cipla Health has 26 GST registrations: 24 active and 2 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCC1585R1ZZ | Maharashtra | Active | 01 Jul 2017 |
| 27AAGCC1585R2ZY | Maharashtra | Active | 28 Jul 2017 |
| 02AAGCC1585R1ZB | Himachal Pradesh | Active | 01 Jul 2017 |
| 03AAGCC1585R1Z9 | Punjab | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Cipla Health Limited, buy the company report.
Recent activity
Cipla Health Limited has 18 board changes on record since 2019: 6 appointments and 12 cessations. The latest: Geena Malhotra ceased to be Additional Director on 28 May 2024.
9 earlier events are in the company report.
News
Frequently asked questions
Cipla Health is an active public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 August 2015 (11+ years old) and is registered under CIN U24100MH2015PLC267880.
Cipla Health has 6 current directors:
- Shivam Puri - Managing Director
- Geena Malhotra - Director
- Umang Vohra - Director
- Chandrashekhar Ramachandran Iyer - Director
- Achin Gupta - Director
- Amrita Nautiyal - Director
The latest financial statements of Cipla Health on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 02 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Cipla Health is 27AAGCC1585R1ZZ, registered in Maharashtra. The company has 26 GST registrations in all, of which 24 are active and 2 are cancelled or inactive. Other active GSTINs include 27AAGCC1585R2ZY (Maharashtra), 02AAGCC1585R1ZB (Himachal Pradesh), 03AAGCC1585R1Z9 (Punjab).
The CIN (Corporate Identification Number) of Cipla Health is U24100MH2015PLC267880. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cipla Health has 31 court cases on record: 27 filed by the company and 4 filed against it. 17 are pending. Most are in the district courts.
Cipla Health was incorporated on 27 August 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.
Cipla Health has 8 deals on record (3 rights issues, 3 secondary share transfers, 2 funding rounds), with disclosed funding of ₹145.23 Cr; the latest was in March 2021.
The peers of Cipla Health by revenue are Encube Ethicals Private Limited, Sentiss Pharma Private Limited, Innova Captab Limited, Neon Laboratories Limited, Corona Remedies Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Geena Malhotra ceased to be Additional Director on 28 May 2024. Geena Malhotra was appointed as Director on 08 May 2024. Umang Vohra ceased to be Additional Director on 30 Nov 2022. Cipla Health has 18 board changes on record in total.
Cipla Health can be reached through the website ciplahealth.in. Its registered office is in Mumbai, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
